DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Crinetics Pharmaceuticals Q4 EPS $(0.6) Down From $(0.35) YoY

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.6) per share. This is a 71.43 percent decrease over losses of $(0.35) per share from the same period last year.

Benzinga · 03/09/2020 20:13

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.6) per share. This is a 71.43 percent decrease over losses of $(0.35) per share from the same period last year.